@ARTICLE{
author={Mancuso ME,Ozelo M,Janic Dragana M,Matytsina Irina,Landorph Andrea,Zeuthan Niels,Roveda A,Pellegrino G},
year={2015},
title={Changes in Annualized Bleeding Rate Over Time and Relationship with Dosing of Tutoctocog a During the Guardian Program},
journal={HAEMATOLOGICA},
volume={100},
number={},
pages={65-66},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Lentz SR,Misgav M,Ozelo MC,Salek SZ,Veljkovic Dobrila K,Recht M,Cerqueira MH,Tiede Andreas,Brand B,Mancuso ME,Seremetis S,Lindblom A,Martinowitz U},
year={2013},
title={Results from a large multinational clinical trial (guardian (TM) 1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy},
journal={HAEMOPHILIA},
volume={19},
number={5},
pages={691-697},
document_type={Article},
} 

@ARTICLE{
author={Lentz SR,Misgav M,Ozelo MC,Zupancic-Salek Silva,Veljkovic Dobrila K,Recht M,Cerqueira MH,Tiede Andreas,Brand B,Mancuso ME,Martinowitz U},
year={2012},
title={Safety and efficacy of turoctocog alfa during prevention and treatment of bleeds in adult and adolescent patients with severe haemophilia A},
journal={HAEMOPHILIA},
volume={18},
number={5},
pages={829-830},
document_type={Meeting Abstract},
}